NAMS fundamentals
NewAmsterdam Pharma Company N.V. financial statements, including revenue, expenses, and profit
The total revenue of NAMS for the last quarter is 12.77 M USD, and it's 56.13% lower compared to the previous quarter. The net income of Q4 24 is -92.18 M USD.
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM